NASDAQ:BVXV
BiondVax Pharmaceuticals Ltd.
- Stock
Last Close
1.35
06/09 19:59
Market Cap
4.97M
Beta: 2.47
Volume Today
22.67K
Avg: 41.50K
PE Ratio
0.59
PFCF: −3.53
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -8.04M - | -7.76M 3.38% | -10.20M 31.36% | -9.18M 9.95% | -34.55M 276.21% | -87.73M 153.91% | -109.19M 24.47% | -4.46M 95.92% | -39.98M 797.37% | -5.80M 85.50% | |
depreciation and amortization | 709K - | 677K 4.51% | 628K 7.24% | 621K 1.11% | 440K 29.15% | 260K 40.91% | 1.65M 532.69% | 2.44M 48.09% | 2.42M 0.86% | 562K 76.73% | |
deferred income tax | 140K - | 59K 57.86% | 2K 96.61% | 42K 2,000% | -53K 226.19% | 51K 196.23% | -122K 339.22% | -37K 69.67% | -33K 10.81% | ||
stock based compensation | 562K - | 363K 35.41% | 745K 105.23% | 1.26M 69.26% | 519K 58.84% | 260K 49.90% | 3.68M 1,316.92% | 9.47M 157.11% | 8.90M 6.00% | 1.60M 82.01% | |
change in working capital | 2.02M - | -529K 126.12% | -339K 35.92% | 323K 195.28% | 2.40M 643.03% | 31.42M 1,209.13% | 11.03M 64.90% | -92.73M 940.98% | 5.18M 105.58% | 271K 94.77% | |
accounts receivables | |||||||||||
inventory | |||||||||||
accounts payables | -12K - | 132K 1,200% | 415K 214.39% | -238K 157.35% | 5.54M 2,426.47% | 14.50M 161.87% | -3.66M 125.25% | -15.19M 315.02% | 1.24M 108.15% | -175K 114.12% | |
other working capital | 2.04M - | -661K 132.45% | -754K 14.07% | 561K 174.40% | -3.14M 659.18% | 16.92M 639.34% | 14.69M 13.19% | -77.54M 627.92% | 3.94M 105.08% | 446K 88.68% | |
other non cash items | 535K - | -319K 159.63% | -1.10M 245.45% | -2.67M 142.65% | 21.14M 890.65% | -1.46M 106.89% | 15.90M 1,192.17% | 12.78M 19.63% | -970K 107.59% | -3.90M 302.47% | |
net cash provided by operating activities | -4.21M - | -7.57M 80.07% | -10.27M 35.59% | -9.65M 5.98% | -10.05M 4.11% | -57.19M 469.08% | -77.06M 34.73% | -72.54M 5.86% | -24.48M 66.25% | -7.26M 70.33% | |
investments in property plant and equipment | -196K - | -30K 84.69% | -34K 13.33% | -20K 41.18% | -4.51M 22,440% | -23.73M 426.42% | -7.43M 68.69% | -6.13M 17.46% | -430K 92.99% | -836K 94.42% | |
acquisitions net | |||||||||||
purchases of investments | |||||||||||
sales maturities of investments | 2.08M - | 4.07M - | |||||||||
other investing activites | 141K - | -150K 206.38% | -9K 94% | -7.79M 86,488.89% | 7.20M 192.39% | 277K 96.15% | 230K 16.97% | 197K 14.35% | 69K 64.97% | ||
net cash used for investing activites | 2.02M - | -180K 108.89% | -43K 76.11% | -7.81M 18,069.77% | 6.76M 186.51% | -23.45M 447.00% | -7.20M 69.31% | -5.93M 17.56% | -361K 93.92% | -836K 131.58% | |
debt repayment | -581K - | -1.24M 113.43% | -1.22M 1.61% | ||||||||
common stock issued | 9.25M - | 27.32M - | 55.69M - | 70.27M - | 69.00M - | 932K 98.65% | |||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | -782K - | 6.43M 922.25% | 6.15M - | 84.32M 1,271.74% | 15.53M 81.59% | 14.96M 3.67% | 5.84M - | ||||
net cash used provided by financing activities | 9.25M - | -782K 108.46% | 33.75M 4,416.24% | 61.84M - | 84.32M 36.36% | 85.21M 1.06% | 13.72M 83.90% | 67.78M 394.19% | 6.78M 90.00% | ||
effect of forex changes on cash | -233K - | 283K 221.46% | 415K 46.64% | -299K 172.05% | -2.87M 860.20% | 827K 128.81% | -4.37M 628.78% | 1.71M 139.15% | 1.68M 2.04% | -1.98M 217.89% | |
net change in cash | 6.83M - | -8.25M 220.73% | 23.86M 389.15% | -17.77M 174.46% | 55.68M 413.41% | 4.50M 91.92% | -3.42M 175.89% | -63.05M 1,745.61% | 44.62M 170.77% | -3.30M 107.40% | |
cash at beginning of period | 11.03M - | 17.86M 61.96% | 9.61M 46.19% | 33.47M 248.21% | 15.71M 53.08% | 71.38M 354.52% | 75.88M 6.31% | 72.47M 4.50% | 9.42M 87.00% | 17.52M 85.94% | |
cash at end of period | 17.86M - | 9.61M 46.19% | 33.47M 248.21% | 15.71M 53.08% | 71.38M 354.52% | 75.88M 6.31% | 72.47M 4.50% | 9.42M 87.00% | 54.04M 473.57% | 14.21M 73.69% | |
operating cash flow | -4.21M - | -7.57M 80.07% | -10.27M 35.59% | -9.65M 5.98% | -10.05M 4.11% | -57.19M 469.08% | -77.06M 34.73% | -72.54M 5.86% | -24.48M 66.25% | -7.26M 70.33% | |
capital expenditure | -196K - | -30K 84.69% | -34K 13.33% | -20K 41.18% | -4.51M 22,440% | -23.73M 426.42% | -7.43M 68.69% | -6.13M 17.46% | -430K 92.99% | -836K 94.42% | |
free cash flow | -4.40M - | -7.60M 72.73% | -10.30M 35.50% | -9.67M 6.10% | -14.56M 50.50% | -80.92M 455.87% | -84.49M 4.40% | -78.67M 6.88% | -24.91M 68.33% | -8.10M 67.48% |
All numbers in USD (except ratios and percentages)